Advertisment

Indian Journal of Nephrology About us |  Subscription |  e-Alerts  | Feedback | Login   
  Print this page Email this page   Small font sizeDefault font sizeIncrease font size
 Home | Current Issue | Archives| Ahead of print | Search |Instructions |  Editorial Board  

Users Online:1298

Official publication of the Indian Society of Nephrology
  Search
 
  
 ~  Similar in PUBMED
 ~  Search Pubmed for
 ~  Search in Google Scholar for
 ~  Article in PDF (93 KB)
 ~  Citation Manager
 ~  Access Statistics
 ~  Reader Comments
 ~  Email Alert *
 ~  Add to My List *
* Registration required (free)  

 

 Article Access Statistics
    Viewed1371    
    Printed35    
    Emailed0    
    PDF Downloaded143    
    Comments [Add]    

Recommend this journal

 


 
  Table of Contents  
CHAPTER 1
Year : 2016  |  Volume : 26  |  Issue : 7  |  Page : 1
 

Preface


Secretary, Indian Society of Nephrology

Date of Web Publication27-Apr-2016

Correspondence Address:
Vivekanand Jha
Secretary, Indian Society of Nephrology

Login to access the Email id

Source of Support: None, Conflict of Interest: None


Rights and PermissionsRights and Permissions



How to cite this article:
Jha V. Preface. Indian J Nephrol 2016;26, Suppl S1:1

How to cite this URL:
Jha V. Preface. Indian J Nephrol [serial online] 2016 [cited 2022 Dec 5];26, Suppl S1:1. Available from: https://www.indianjnephrol.org/text.asp?2016/26/7/1/181293


Chronic kidney disease (CKD), no matter what is the cause, has a profound effect on both innate and adaptive immune system. This is specially exaggerated in dialysis patients and amongst kidney transplant recipients, leads to an increased risk of infections. Besides being the second leading cause of death in patients with CKD, infections also increase the risk for cardiovascular events and lead to catastrophic healthcare expenditure secondary to invasive diseases and hospitalizations.

Along with improved sanitation, immunisation is humanity's greatest advances in preventing sickness and death from infectious diseases. Vaccines have helped eliminate or significantly reduce the burden of more than a dozen illnesses. Recognising that childhood is the best time to provide lifelong protection against infections, most countries have pout in place universal immunisation programs.

Specific recommendations are available for adults as well, but these are less well implemented. Various factors may account for these low rates, including financial disincentives.

Overall, prevention through vaccination remains the best strategy to minimise the adverse consequences associated with these infectious diseases in patients with CKD. Protection against hepatitis B infection is a great success story. However, vaccine efficacy his suboptimal in this population, secondary to the same deficiencies in the immune response that increase infection risk. Getting around this barrier needs innovative approaches, such as use of nonspecific adjuvant compounds to enhance host response. by targeting important cellular elements of the vaccine response.

We need more research in this area, to better understand how vaccination in populations at risk for developing CKD might benefit from earlier vaccination, and to expand repertoire of vaccines available against particularly troublesome pathogens, particularly MRSA, Group A streptococcus and other bacteria. Next-generation vaccines offer the possibility of sustained immunological memory, which can substantially prevent chronic viral disease.

In addition, we need to change behaviour so that nephrologists become sensitised to the notion of prevention rather than treating infection after they become apparent. Nephrologists need to be steadfast proponents of vaccination.

Current guidelines recommend immunisations for all patients with CKD regardless of the disease stage, but they are recommended during the early stages of progressive renal disease to increase the likelihood of vaccine-induced immunity.

This document is intended to help the Indian physician community who take care of patients with kidney disease make informed decisions about this often overlooked aspect of care.

The document has been prepared by leading nephrology academics and clinicians who have examined all aspects of vaccination, culled evidence from CKD population and where this was not available, from the general population.

As usual, this document is intended to inform practice, rather than provide specific guidance about every single patient. Practitioners are encouraged to implement the suggestions and recommendations keeping in mind the specific clinical context of the patient.




 

Top
Print this article  Email this article
 

    

Indian Journal of Nephrology
Published by Wolters Kluwer - Medknow
Online since 20th Sept '07